#Roche
2 articles with this tag
Funding Round
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.
6 months ago
Interview
This Israeli Startup Is Using AI To Revolutionize Pathology
almost 7 years ago